Get a glimpse into our company and investor data—powered by the PitchBook Platform
Accelerator/IncLATEST DEAL TYPE
$25KLATEST DEAL AMOUNT
Developer of medical products intended to control nosebleeds. The company's medical products include single-use prescription product targeted for anticoagulated patients, enabling patients to avail the products at a reasonable rate.